✦ LIBER ✦

Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: A randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg

✍ Scribed by Horst Herrschaft; Anatol Nacu; Sergey Likhachev; Ilya Sholomov; Robert Hoerr; Sandra Schlaefke

Book ID: 113751049
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 384 KB
Volume: 46
Category: Article
ISSN: 0022-3956
DOI: 10.1016/j.jpsychires.2012.03.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of a once-daily form

Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial

✍ Ralf Ihl; Natalia Bachinskaya; Amos D. Korczyn; Veronika Vakhapova; Michael Trib 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB

## Abstract ## Objective To test the efficacy and safety of a once‐daily formulation of EGb 761 in the treatment of patients with dementia with neuropsychiatric features. ## Methods Multi‐centre trial of 410 outpatients with mild to moderate dementia (Alzheimer's disease, vascular dementia or mi

Efficacy and safety of Ginkgo biloba ext

Efficacy and safety of Ginkgo biloba extract EGb 761 ® in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial

✍ Gavrilova, S. I.; Preuss, U. W.; Wong, J. W. M.; Hoerr, R.; Kaschel, R.; Bachins 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

Baseline neuropsychiatric symptoms are e

Baseline neuropsychiatric symptoms are effect modifiers in Ginkgo biloba extract (EGb 761®) treatment of dementia with neuropsychiatric features. Retrospective data analyses of a randomized controlled trial

✍ R. Ihl; M. Tribanek; N. Bachinskaya 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 372 KB

O3-04-03: A 240-mg once-daily formulatio

O3-04-03: A 240-mg once-daily formulation of Ginkgo Biloba extract EGb 761® is effective in both Alzheimer's disease and vascular dementia: Results from a randomized controlled trial

✍ Ralf Ihl; Michael Tribanek; Oleksandr Napryeyenko 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Randomised clinical trial: a multicentre

Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease

✍ Y. Kinoshita; K. Ashida; M. Hongo; The Japan Rabeprazole Study Group for NERD 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

80* A randomised, double-blind, placebo-

80* A randomised, double-blind, placebo-controlled parallel group study to investigate the safety and efficacy of two doses of tiotropium bromide (2.5 μg and 5 μg) administered once daily via the Respimat® device for 12 weeks in patients with cystic fibrosis

✍ J.S. Elborn; A. Sharma; Q. Deng; P. Koker 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 51 KB